Joyson Karakunnel
Chief Tech/Sci/R&D Officer chez ITEOS THERAPEUTICS, INC.
Profil
Joyson Joseph Karakunnel is currently the Director at Precision Biologics, Inc. and the Chief Medical Officer at iTeos Therapeutics, Inc. He previously worked as the Medical Director at The Parker Institute For Cancer Immunotherapy, the Director at MedImmune LLC, the Chief Medical Officer & Executive Vice President at Innate Pharma SA, the Associate Professor at Uniformed Services University of the Health Sciences, and the Chief Medical Officer & Senior Vice President at Tizona Therapeutics, Inc. He also held the position of Vice President-Clinical Development at Arcus Biosciences, Inc. Dr. Karakunnel is a graduate of the University of Maryland, with an undergraduate degree from the University of Miami and a doctorate from Annamalai University.
Postes actifs de Joyson Karakunnel
| Sociétés | Poste | Début |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Corporate Officer/Principal | - |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Chief Tech/Sci/R&D Officer | 01/04/2017 |
Precision Biologics, Inc.
 Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Director/Board Member | 01/01/2022 |
Anciens postes connus de Joyson Karakunnel
| Sociétés | Poste | Fin |
|---|---|---|
| INNATE PHARMA | Chief Tech/Sci/R&D Officer | 31/10/2023 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | 01/04/2017 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Director/Board Member | 01/04/2017 |
| ARCUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Joyson Karakunnel
| University of Maryland | Graduate Degree |
| University of Miami | Undergraduate Degree |
| Annamalai University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INNATE PHARMA | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Precision Biologics, Inc.
Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Retail Trade |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Commercial Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
